Lacosamide and Grieving - a phase IV clinical study of FDA data
Summary:
We study 16,762 people who take Lacosamide (lacosamide) or have Grieving. No report of Grieving is found in people who take Lacosamide.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Lacosamide?
Lacosamide has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 16,601 Lacosamide users. Check the latest studies of Lacosamide.
What is Grieving?
Grieving (grieving is not the elimination of all the pain or the memories of the loss) is found to be associated with 71 drugs and 76 conditions by eHealthMe. Check the latest studies of Grieving.
No report is found.
Do you take Lacosamide and have Grieving?
- Check whether Grieving is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lacosamide:
- Lacosamide (16,601 reports)
Grieving treatments and more:
- Grieving (161 reports)
How severe was Grieving and when was it recovered:
Expand to all the drugs that have ingredients of lacosamide:
Browse all side effects of Lacosamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Grieving:
Browse all the conditions that are associated with Grieving:
How the study uses the data?
The study uses data from the FDA. It is based on lacosamide (the active ingredients of Lacosamide) and Lacosamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fever and drugs of ingredients of asparaginase - 4 seconds ago
- Fever and drugs of ingredients of acetazolamide - 14 seconds ago
- Niacin and Atrial Fibrillation/Flutter for Men aged 60+ - 16 seconds ago
- Niacin and Heart Fibrillation for Men aged 60+ - 16 seconds ago
- Niacin and Atrial Flutter for Men aged 60+ - 16 seconds ago
- Niacin and Atrial Fibrillation for Men aged 60+ - 17 seconds ago
- Niacin and A-Fib for Men aged 60+ - 17 seconds ago
- Niacin and Auricular Fibrillation for Men aged 60+ - 17 seconds ago
- Imodium and Blood Glucose Increased for Women aged 60+ - 18 seconds ago
- Kaletra and Lamivudine drug interactions for boys aged 0-1 - 45 seconds ago